Allopurinol use and risk of non-fatal acute myocardial infarction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Allopurinol use and risk of non-fatal acute myocardial infarction

Published:2015-01-05 Issue:9 Volume:101 Page:679-685
ISSN:1355-6037
Container-title:Heart
language:en
Short-container-title:Heart

Author:

de Abajo Francisco J,Gil Miguel J,Rodríguez Antonio,García-Poza Patricia,Álvarez Arturo,Bryant Verónica,García-Rodríguez Luis A

Publisher

BMJ

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT);Zhang;Ann Rheum Dis,2006

2. Gout;Richette;Lancet,2010

3. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol;Pacher;Pharmacol Rev,2006

4. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase;Landmesser;Circulation,2002

5. Role of oxidative stress in atherosclerosis;Harrison;Am J Cardiol,2003

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asymptomatic hyperuricemia: to treat or not a threat? A clinical and evidence-based approach to the management of hyperuricemia in the context of cardiovascular diseases;Journal of Hypertension;2024-07-10

2. The association of allopurinol with persistent physical disability and frailty in a large community based older cohort;Journal of the American Geriatrics Society;2023-05-09

3. The potential relationship of coronary artery disease and hyperuricemia: A cardiometabolic risk factor;Heliyon;2023-05

4. Frontiers and hotspots evolution in anti-inflammatory studies for coronary heart disease: A bibliometric analysis of 1990–2022;Frontiers in Cardiovascular Medicine;2023-02-16

5. Allopurinol to reduce cardiovascular morbidity and mortality: A systematic review and meta-analysis;PLOS ONE;2021-12-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3